Search results for "Diabetes"


 
Results 1 - 10 of about 938 for "Diabetes".
Sort by: Relevance | Newest | Oldest

Higher aspirin dose no more effective for CV prevention in high-risk patients with diabetes

A subgroup analysis of a randomized trial found that patients with diabetes and atherosclerotic cardiovascular disease had similar outcomes whether they took 81 mg or 325 mg of aspirin daily.
https://acpinternist.org/weekly/archives/2023/09/26/2.htm
26 Sep 2023

PrEPare for HIV care

Internal medicine physicians are already trained to care for complex medical conditions, and HIV is no different, especially as adults age and develop diabetes, heart disease, and other conditions.
https://acpinternist.org/archives/2023/11/prepare-for-hiv-care.htm
1 Nov 2023

Subscribe

ACP Internist provides news and information for internal medicine physicians about the practice of medicine and reports on the policies, products, and activities of ACP.
https://acpinternist.org/subscribe/

‘Night owls' more likely to have unhealthy lifestyles, higher diabetes risk

In a retrospective cohort study, people with an evening chronotype were more likely to smoke, sleep poorly, and be physically inactive and had a 72% higher risk for diabetes than those with a morning chronotype.
https://acpinternist.org/weekly/archives/2023/09/12/2.htm
12 Sep 2023

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://acpinternist.org/archives/2023/09/spotlight.htm
1 Sep 2023

Almost 4 in 10 with type 1 diabetes were diagnosed in adulthood

Peak diagnosis age was approximately 15 years, and the median age of diagnosis was 24 years, but 37% of adults with type 1 diabetes reported having been diagnosed after age 30 years in a recent study.
https://acpinternist.org/weekly/archives/2023/09/26/1.htm
26 Sep 2023

SGLT-2 inhibitors reduced gout flares in patients with diabetes, gout

New users of sodium-glucose cotransporter-2 (SGLT-2) inhibitors had about half the risk of an ED visit or hospitalization for a gout flare as matched patients taking dipeptidyl peptidase-4 inhibitors, a cohort analysis found.
https://acpinternist.org/weekly/archives/2023/07/25/1.htm
25 Jul 2023

Factoring drug costs into diabetes decisions

A sizable number of patients with diabetes do not consistently fill their prescriptions or take less than the prescribed amount due to costs, but there are ways to make it easier on a patient's pocketbook.
https://acpinternist.org/archives/2022/05/factoring-drug-costs-into-diabetes-decisions.htm
1 May 2022

Large review compares benefits, harms of drugs to treat type 2 diabetes

High-certainty evidence indicated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists reduce all-cause death, while finerenone probably also reduced mortality based on moderate-certainty evidence.
https://acpinternist.org/weekly/archives/2023/04/18/4.htm
18 Apr 2023

Marking achievements in gender equity

The President-elect of the American Medical Women's Association discusses mentorship, advocacy, and more.
https://acpinternist.org/archives/2023/09/marking-achievements-in-gender-equity.htm
1 Sep 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next